Thrombin generation and implications for hemophilia therapies: A
Por um escritor misterioso
Descrição
Feasibility of Using Thrombin Generation Assay (TGA) for
Factor VIII (FVIII) - DiaPharma
PDF] Thrombin generation and whole blood viscoelastic assays in
Endogenous thrombin potential following hemostatic therapy with 4
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables
Novel Insights and New Developments Regarding Coagulation Revealed
Treatment of acute bleeding in acquired haemophilia A with
Assessment of global coagulation function under treatment with
Thrombin generation for monitoring hemostatic therapy in
Defining the Boundaries of Normal Thrombin Generation
Antithrombin inhibition using nanobodies to correct bleeding in
Low normal factor V enhances thrombin generation in hemophilia A
Advances in Hemophilia A Management - Advances in Pediatrics
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables